Valeria Ciaffaglione
Catania, 95125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Semi-Synthetic H2S Releasing Compounds with Antioxidant and Vasorelaxant Properties.
Journal: ACS medicinal chemistry letters
Published: October 16, 2025
Carnosine Biofunctionalized Hydroxyapatite Induces Copper-Driven Osteogenesis and Angiogenesis, Strengthening Its Bone Regenerative Capacities.
Journal: ACS biomaterials science & engineering
Published: August 31, 2025
SUMO-2 activity is inhibited by non-covalent interactions with the Aβ peptide: an exploration of potential pathogenic mechanisms in Alzheimer's disease.
Journal: International journal of biological macromolecules
Published: June 05, 2025
Carnosine, Zinc and Copper: A Menage a Trois in Bone and Cartilage Protection.
Journal: International journal of molecular sciences
Published: October 03, 2023
Novel Heme Oxygenase-1 Inducers Palliate Inflammatory Pain and Emotional Disorders by Regulating NLRP3 Inflammasome and Activating the Antioxidant Pathway.
Journal: Antioxidants (Basel, Switzerland)
Published: August 25, 2023
Copper(II) Complexes with Carnosine Conjugates of Hyaluronic Acids at Different Dipeptide Loading Percentages Behave as Multiple SOD Mimics and Stimulate Nrf2 Translocation and Antioxidant Response in In Vitro Inflammatory Model.
Journal: Antioxidants (Basel, Switzerland)
Published: July 10, 2023
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects.
Journal: Bioorganic & medicinal chemistry
Published: July 28, 2022
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia.
Journal: Molecules (Basel, Switzerland)
Published: March 21, 2022
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 25, 2021
Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.
Journal: Molecules (Basel, Switzerland)
Published: May 14, 2021
New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.
Journal: International journal of molecular sciences
Published: February 18, 2020
Last Updated: 09/26/2026